Rigel Pharmaceuticals, Inc.(RIGL)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | Ali-Jackson Kamil Director | Sale | -2,500 | -16.53%12,625 | $29.17 | $72,925 | View SEC filing | |
| 2026-02-24 | MOOS WALTER H Director | Sale | -4,000 | -23.92%12,722 | $36.36 | $145,440 | View SEC filing | |
| 2025-02-06 | Schorno Dean L EVP & Chief Financial Officer | Sale | -3,770 | -6.18%57,235 | $21.38 | $80,615 | View SEC filing | |
| 2025-02-06 | Santos David A EVP, Chief Commercial Officer | Sale | -3,921 | -7.05%51,704 | $21.38 | $83,836 | View SEC filing | |
| 2025-02-06 | RODRIGUEZ RAUL R CEO, President | Sale | -9,352 | -3.76%239,454 | $21.39 | $200,075 | View SEC filing | |
| 2025-02-06 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Sale | -2,787 | -6.70%38,830 | $21.40 | $59,653 | View SEC filing | |
| 2024-02-06 | Santos David A EVP, Chief Commercial Officer | Sale | -14,519 | -3.99%349,093 | $1.14 | $16,496 | View SEC filing | |
| 2024-02-06 | Schorno Dean L EVP & Chief Financial Officer | Sale | -12,628 | -3.04%402,891 | $1.14 | $14,338 | View SEC filing | |
| 2024-02-06 | RODRIGUEZ RAUL R CEO, President | Sale | -52,894 | -2.53%2,036,629 | $1.14 | $60,082 | View SEC filing | |
| 2023-02-07 | RODRIGUEZ RAUL R CEO, President | Sale | -20,340 | -1.20%1,680,713 | $1.75 | $35,595 | View SEC filing | |
| 2023-02-06 | Santos David A EVP, Chief Commercial Officer | Sale | -5,388 | -3.59%144,612 | $1.66 | $8,945 | View SEC filing | |
| 2023-02-06 | Schorno Dean L EVP & Chief Financial Officer | Sale | -5,389 | -2.67%196,519 | $1.66 | $8,946 | View SEC filing | |
| 2023-02-06 | Dummer Wolfgang EVP & CMO | Sale | -5,389 | -6.92%72,459 | $1.66 | $8,946 | View SEC filing | |
| 2022-06-13 | RODRIGUEZ RAUL R CEO, President | Purchase | +1,000,000 | +255.25%1,391,776 | $0.69 | $688,400 | View SEC filing | |
| 2019-11-20 | Masuda Esteban Sr. VP Research | Sale | +62,500 | +100.00%62,500 | N/A | N/A | View SEC filing | |
| 2019-05-23 | Schorno Dean L EVP &Chief Financial Officer | Purchase | +50,000 | +100.00%50,000 | $2.13 | $106,544 | View SEC filing | |
| 2018-10-16 | Cabatuan Nelson Principal Accounting Officer | Sale | -10,000 | -99.42%58 | $3.12 | $31,200 | View SEC filing | |
| 2018-09-19 | Duliege Anne-Marie EVP & Chief Medical Officer | Sale | -153,000 | -100.00%0 | $3.50 | $535,500 | View SEC filing | |
| 2018-09-12 | Mayer Eldon C. III EVP & Chief Commercial Officer | Purchase | +100,000 | +86.96%215,000 | $3.26 | $325,550 | View SEC filing | |
| 2018-09-06 | Duliege Anne-Marie EVP & Chief Medical Officer | Sale | -16,500 | -100.00%0 | $3.51 | $57,861 | View SEC filing | |
| 2018-08-27 | Mayer Eldon C. III EVP & Chief Commercial Officer | Purchase | +100,000 | +666.67%115,000 | $2.82 | $282,320 | View SEC filing | |
| 2018-08-21 | RODRIGUEZ RAUL R CEO, President | Purchase | +114,000 | +191.54%173,519 | $2.63 | $300,002 | View SEC filing | |
| 2018-07-05 | Duliege Anne-Marie EVP & Chief Medical Officer | Sale | -5,000 | -100.00%0 | $2.79 | $13,932 | View SEC filing | |
| 2018-04-24 | Duliege Anne-Marie EVP & Chief Medical Officer | Sale | -5,000 | -100.00%0 | $4.11 | $20,550 | View SEC filing | |
| 2017-11-07 | Maynard Ryan D EVP & CFO | Sale | -100,000 | -100.00%0 | $3.90 | $390,000 | View SEC filing |
1-25 of 167